<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33729613</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4547</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of neuroscience research</Title><ISOAbbreviation>J Neurosci Res</ISOAbbreviation></Journal><ArticleTitle>Synaptic dysfunction in amyotrophic lateral sclerosis/frontotemporal dementia: Therapeutic strategies and novel biomarkers.</ArticleTitle><Pagination><StartPage>1499</StartPage><EndPage>1503</EndPage><MedlinePgn>1499-1503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jnr.24824</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krishnamurthy</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2552-8912</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Jefferson Weinberg ALS Center, Vickie &amp; Jack Farber Institute for Neuroscience, Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasinelli</LastName><ForeName>Piera</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Jefferson Weinberg ALS Center, Vickie &amp; Jack Farber Institute for Neuroscience, Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS109150</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS092572</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci Res</MedlineTA><NlmUniqueID>7600111</NlmUniqueID><ISSNLinking>0360-4012</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">liquid-liquid phase separation</Keyword><Keyword MajorTopicYN="N">motor neuron disease/amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword><Keyword MajorTopicYN="N">synaptic dysfunction</Keyword><Keyword MajorTopicYN="N">synaptotagmin</Keyword></KeywordList><CoiStatement>Conflict of Interest. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>17</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33729613</ArticleId><ArticleId IdType="mid">NIHMS1679747</ArticleId><ArticleId IdType="pmc">PMC8085061</ArticleId><ArticleId IdType="doi">10.1002/jnr.24824</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Armstrong GA, Drapeau P. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum Mol Genet. 2013. November 1;22(21):4282&#x2013;92. doi: 10.1093/hmg/ddt278. Epub 2013 Jun 13. PubMed PMID: 23771027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt278</ArticleId><ArticleId IdType="pubmed">23771027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae JS, Simon NG, Menon P, Vucic S, Kiernan MC. The puzzling case of hyperexcitability in amyotrophic lateral sclerosis. J Clin Neurol. 2013. April;9(2):65&#x2013;74. doi: 10.3988/jcn.2013.9.2.65. Epub 2013 Apr 4. PubMed PMID: 23626643; PubMed Central PMCID: PMC3633193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2013.9.2.65</ArticleId><ArticleId IdType="pmc">PMC3633193</ArticleId><ArticleId IdType="pubmed">23626643</ArticleId></ArticleIdList></Reference><Reference><Citation>Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008. February 15;319(5865):916&#x2013;9. doi: 10.1126/science.1141448. Review. PubMed PMID: 18276881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1141448</ArticleId><ArticleId IdType="pubmed">18276881</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A, Alberici A, Buratti E, Ghidoni R, Gardoni F, Di Luca M, Padovani A, Borroni B. Toward a Glutamate Hypothesis of Frontotemporal Dementia. Front Neurosci. 2019;13:304. doi: 10.3389/fnins.2019.00304. eCollection 2019. Review. PubMed PMID: 30983965; PubMed Central PMCID: PMC6449454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00304</ArticleId><ArticleId IdType="pmc">PMC6449454</ArticleId><ArticleId IdType="pubmed">30983965</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013. June;125(6):777&#x2013;94. doi: 10.1007/s00401-013-1125-6. Epub 2013 May 15. Review. PubMed PMID: 23673820; PubMed Central PMCID: PMC3661910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden HA, Dormann D. Altered mRNP granule dynamics in FTLD pathogenesis. J Neurochem. 2016. August;138 Suppl 1:112&#x2013;33. doi: 10.1111/jnc.13601. Epub 2016 Jun 15. Review. PubMed PMID: 26938019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13601</ArticleId><ArticleId IdType="pubmed">26938019</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I, Krishnamurthy K, Kour S, Tripathy V, Ramesh N, Anderson EN, Marrone L, Grant RA, Oliver S, Gochenaur L, Patel K, Sterneckert J, Gleixner AM, Donnelly CJ, Ruepp MD, Sini AM, Zuccaro E, Pennuto M, Pasinelli P, Pandey UB. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization. Nat Commun. 2019. December 6;10(1):5583. doi: 10.1038/s41467-019-13383-z. PubMed PMID: 31811140; PubMed Central PMCID: PMC6898697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13383-z</ArticleId><ArticleId IdType="pmc">PMC6898697</ArticleId><ArticleId IdType="pubmed">31811140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P, Kundra R, Morimoto RI, Dobson CM, Vendruscolo M. Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases. Trends Pharmacol Sci. 2015. February;36(2):72&#x2013;7. doi: 10.1016/j.tips.2014.12.004. Epub 2015 Jan 27. Review. PubMed PMID: 25636813; PubMed Central PMCID: PMC4643722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2014.12.004</ArticleId><ArticleId IdType="pmc">PMC4643722</ArticleId><ArticleId IdType="pubmed">25636813</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle JG, Krishnamurthy K, Ramesh N, Casci I, Monaghan J, McAvoy K, Godfrey EW, Daniel DC, Johnson EM, Monahan Z, Shewmaker F, Pasinelli P, Pandey UB. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity. Acta Neuropathol. 2016. April;131(4):605&#x2013;20. doi: 10.1007/s00401-015-1530-0. Epub 2016 Jan 4. PubMed PMID: 26728149; PubMed Central PMCID: PMC4791193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1530-0</ArticleId><ArticleId IdType="pmc">PMC4791193</ArticleId><ArticleId IdType="pubmed">26728149</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Zeng M, Chen X, Zhang M. Neuronal Synapses: Microscale Signal Processing Machineries Formed by Phase Separation?. Biochemistry. 2018. May 1;57(17):2530&#x2013;2539. doi: 10.1021/acs.biochem.8b00313. Epub 2018 Apr 19. Review. PubMed PMID: 29648450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.8b00313</ArticleId><ArticleId IdType="pubmed">29648450</ArticleId></ArticleIdList></Reference><Reference><Citation>Glavan G, Schliebs R, Zivin M. Synaptotagmins in neurodegeneration. Anat Rec (Hoboken). 2009. December;292(12):1849&#x2013;62. doi: 10.1002/ar.21026. Review. PubMed PMID: 19943339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.21026</ArticleId><ArticleId IdType="pubmed">19943339</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, Jicha GA, Karydas AM, Boxer A, Miller BL. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease. FASEB J. 2016. December;30(12):4141&#x2013;4148. doi: 10.1096/fj.201600816R. Epub 2016 Sep 6. PubMed PMID: 27601437; PubMed Central PMCID: PMC5102122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600816R</ArticleId><ArticleId IdType="pmc">PMC5102122</ArticleId><ArticleId IdType="pubmed">27601437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes E, Shorter J. The molecular language of membraneless organelles. J Biol Chem. 2019. May 3;294(18):7115&#x2013;7127. doi: 10.1074/jbc.TM118.001192. Epub 2018 Jul 25. Review. PubMed PMID: 30045872; PubMed Central PMCID: PMC6509512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001192</ArticleId><ArticleId IdType="pmc">PMC6509512</ArticleId><ArticleId IdType="pubmed">30045872</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Handley E, Brizuela M, Dawkins E, Lewis KEA, Clark RM, Dickson TC, Blizzard CA. Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function. Dis Model Mech. 2019. May 17;12(5). doi: 10.1242/dmm.038109. PubMed PMID: 31036551; PubMed Central PMCID: PMC6550035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.038109</ArticleId><ArticleId IdType="pmc">PMC6550035</ArticleId><ArticleId IdType="pubmed">31036551</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR, King OD, Shorter J, Gitler AD. Stress granules as crucibles of ALS pathogenesis. J Cell Biol. 2013. April 29;201(3):361&#x2013;72. doi: 10.1083/jcb.201302044. Review. PubMed PMID: 23629963; PubMed Central PMCID: PMC3639398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC. Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions. Neural Plast. 2018;2018:8413496. doi: 10.1155/2018/8413496. eCollection 2018. Review. PubMed PMID: 29755516; PubMed Central PMCID: PMC5925147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8413496</ArticleId><ArticleId IdType="pmc">PMC5925147</ArticleId><ArticleId IdType="pubmed">29755516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013. August 7;79(3):416&#x2013;38. doi: 10.1016/j.neuron.2013.07.033. Review. PubMed PMID: 23931993; PubMed Central PMCID: PMC4411085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J, Tadokoro T, Baughn MW, Myers B, McAlonis-Downes M, Chillon-Marinas C, Asiaban JN, Artates J, Bui AT, Vetto AP, Lee SK, Le AV, Sun Y, Jambeau M, Boubaker J, Swing D, Qiu J, Hicks GG, Ouyang Z, Fu XD, Tessarollo L, Ling SC, Parone PA, Shaw CE, Marsala M, Lagier-Tourenne C, Cleveland DW, Da Cruz S. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS. Neuron. 2018. November 21;100(4):816&#x2013;830.e7. doi: 10.1016/j.neuron.2018.09.044. Epub 2018 Oct 18. PubMed PMID: 30344044; PubMed Central PMCID: PMC6277851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Margeta MA, Shen K. Molecular mechanisms of synaptic specificity. Mol Cell Neurosci. 2010. March;43(3):261&#x2013;7. doi: 10.1016/j.mcn.2009.11.009. Epub 2009 Dec 5. Review. PubMed PMID: 19969086; PubMed Central PMCID: PMC3168553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2009.11.009</ArticleId><ArticleId IdType="pmc">PMC3168553</ArticleId><ArticleId IdType="pubmed">19969086</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan MC, Vucic S. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin Neurophysiol. 2015. April;126(4):803&#x2013;9. doi: 10.1016/j.clinph.2014.04.023. Epub 2014 Aug 28. PubMed PMID: 25227219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.04.023</ArticleId><ArticleId IdType="pubmed">25227219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzardo M, Taiana M, Rizzo F, Aguila Benitez J, Nijssen J, Allodi I, Melzi V, Bresolin N, Comi GP, Hedlund E, Corti S. Synaptotagmin 13 is neuroprotective across motor neuron diseases. Acta Neuropathol. 2020. May;139(5):837&#x2013;853. doi: 10.1007/s00401-020-02133-x. Epub 2020 Feb 17. PubMed PMID: 32065260; PubMed Central PMCID: PMC7181443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02133-x</ArticleId><ArticleId IdType="pmc">PMC7181443</ArticleId><ArticleId IdType="pubmed">32065260</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S, Mahamid J, Saha S, Franzmann TM, Pozniakovski A, Poser I, Maghelli N, Royer LA, Weigert M, Myers EW, Grill S, Drechsel D, Hyman AA, Alberti S. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell. 2015. August 27;162(5):1066&#x2013;77. doi: 10.1016/j.cell.2015.07.047. PubMed PMID: 26317470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Rage F, Boulisfane N, Rihan K, Neel H, Gostan T, Bertrand E, Bordonn&#xe9; R, Soret J. Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization. RNA. 2013. December;19(12):1755&#x2013;66. doi: 10.1261/rna.040204.113. Epub 2013 Oct 23. PubMed PMID: 24152552; PubMed Central PMCID: PMC3884661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.040204.113</ArticleId><ArticleId IdType="pmc">PMC3884661</ArticleId><ArticleId IdType="pubmed">24152552</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxon JA, Thompson JC, Jones M, Harris JM, Richardson AM, Langheinrich T, Neary D, Mann DM, Snowden JS. Examining the language and behavioural profile in FTD and ALS-FTD. J Neurol Neurosurg Psychiatry. 2017. August;88(8):675&#x2013;680. doi: 10.1136/jnnp-2017-315667. Epub 2017 Jun 8. PubMed PMID: 28596248; PubMed Central PMCID: PMC5537548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315667</ArticleId><ArticleId IdType="pmc">PMC5537548</ArticleId><ArticleId IdType="pubmed">28596248</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxon JA, Thompson JC, Harris JM, Richardson AM, Langheinrich T, Rollinson S, Pickering-Brown S, Chaouch A, Ealing J, Hamdalla H, Young CA, Blackburn D, Majeed T, Gall C, Jones M, Snowden JS. Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020. October 14;. doi: 10.1136/jnnp-2020-323969. [Epub ahead of print] PubMed PMID: 33055142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323969</ArticleId><ArticleId IdType="pmc">PMC7677467</ArticleId><ArticleId IdType="pubmed">33055142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton CF, Tang AA, Kulkarni A, West J, Brooks M, Stubblefield JJ, Liu Y, Zhang MQ, Green CB, Huber KM, Huang EJ, Herz J, Yu G. Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc Natl Acad Sci U S A. 2014. November 4;111(44):E4769&#x2013;78. doi: 10.1073/pnas.1406162111. Epub 2014 Oct 16. PubMed PMID: 25324524; PubMed Central PMCID: PMC4226112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1406162111</ArticleId><ArticleId IdType="pmc">PMC4226112</ArticleId><ArticleId IdType="pubmed">25324524</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidullah M, Le Marchand SJ, Fei H, Zhang J, Pandey UB, Dalva MB, Pasinelli P, Levitan IB. Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS. J Neurosci. 2013. December 11;33(50):19590&#x2013;8. doi: 10.1523/JNEUROSCI.3396-13.2013. PubMed PMID: 24336723; PubMed Central PMCID: PMC3858628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3396-13.2013</ArticleId><ArticleId IdType="pmc">PMC3858628</ArticleId><ArticleId IdType="pubmed">24336723</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin OH. Exocytosis and synaptic vesicle function. Compr Physiol. 2014. January;4(1):149&#x2013;75. doi: 10.1002/cphy.c130021. Review. PubMed PMID: 24692137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c130021</ArticleId><ArticleId IdType="pubmed">24692137</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y Synaptic Actions of Amyotrophic Lateral Sclerosis-Associated G85R-SOD1 in the Squid Giant Synapse. eNeuro. 2020. March/Apr;7(2). doi: 10.1523/ENEURO.0369-19.2020. Print 2020 Mar/Apr. PubMed PMID: 32188708; PubMed Central PMCID: PMC7177748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0369-19.2020</ArticleId><ArticleId IdType="pmc">PMC7177748</ArticleId><ArticleId IdType="pubmed">32188708</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr A, Sattler R. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD. Brain Res. 2018. August 15;1693(Pt A):98&#x2013;108. doi: 10.1016/j.brainres.2018.02.011. Epub 2018 Feb 14. Review. PubMed PMID: 29453960; PubMed Central PMCID: PMC5997509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.02.011</ArticleId><ArticleId IdType="pmc">PMC5997509</ArticleId><ArticleId IdType="pubmed">29453960</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xfc;dhof TC. Towards an Understanding of Synapse Formation. Neuron. 2018. October 24;100(2):276&#x2013;293. doi: 10.1016/j.neuron.2018.09.040. Review. PubMed PMID: 30359597; PubMed Central PMCID: PMC6226307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.040</ArticleId><ArticleId IdType="pmc">PMC6226307</ArticleId><ArticleId IdType="pubmed">30359597</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xfc;dhof TC. The presynaptic active zone. Neuron. 2012. July 12;75(1):11&#x2013;25. doi: 10.1016/j.neuron.2012.06.012. Review. PubMed PMID: 22794257; PubMed Central PMCID: PMC3743085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.06.012</ArticleId><ArticleId IdType="pmc">PMC3743085</ArticleId><ArticleId IdType="pubmed">22794257</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016. November 10;539(7628):197&#x2013;206. doi: 10.1038/nature20413. Review. PubMed PMID: 27830784; PubMed Central PMCID: PMC5585017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh ME, Dammer EB, Dai J, Duong DM, Lah JJ, Levey AI, Gearing M, Glass JD, Seyfried NT. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med. 2018. January;10(1):48&#x2013;62. doi: 10.15252/emmm.201708202. PubMed PMID: 29191947; PubMed Central PMCID: PMC5760858.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708202</ArticleId><ArticleId IdType="pmc">PMC5760858</ArticleId><ArticleId IdType="pubmed">29191947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury JJ, Farrawell NE, McAlary L. Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis. Trends Neurosci. 2020. May;43(5):274&#x2013;284. doi: 10.1016/j.tins.2020.03.002. Epub 2020 Apr 14. Review. PubMed PMID: 32353332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.03.002</ArticleId><ArticleId IdType="pubmed">32353332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, Shang Y, Araki Y, Guo T, Huganir RL, Zhang M. Phase Transition in Postsynaptic Densities Underlies Formation of Synaptic Complexes and Synaptic Plasticity. Cell. 2016. August 25;166(5):1163&#x2013;1175.e12. doi: 10.1016/j.cell.2016.07.008. PubMed PMID: 27565345; PubMed Central PMCID: PMC5564291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.008</ArticleId><ArticleId IdType="pmc">PMC5564291</ArticleId><ArticleId IdType="pubmed">27565345</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lee R, Buljan M, Lang B, Weatheritt RJ, Daughdrill GW, Dunker AK, Fuxreiter M, Gough J, Gsponer J, Jones DT, Kim PM, Kriwacki RW, Oldfield CJ, Pappu RV, Tompa P, Uversky VN, Wright PE, Babu MM. Classification of intrinsically disordered regions and proteins. Chem Rev. 2014. July 9;114(13):6589&#x2013;631. doi: 10.1021/cr400525m. Epub 2014 Apr 29. Review. PubMed PMID: 24773235; PubMed Central PMCID: PMC4095912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr400525m</ArticleId><ArticleId IdType="pmc">PMC4095912</ArticleId><ArticleId IdType="pubmed">24773235</ArticleId></ArticleIdList></Reference><Reference><Citation>von Poser C, S&#xfc;dhof TC. Synaptotagmin 13: structure and expression of a novel synaptotagmin. Eur J Cell Biol. 2001. January;80(1):41&#x2013;7. doi: 10.1078/0171-9335-00133. PubMed PMID: 11211934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/0171-9335-00133</ArticleId><ArticleId IdType="pubmed">11211934</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;hrfelt A, Brinkmalm A, Dumurgier J, Brinkmalm G, Hansson O, Zetterberg H, Bouaziz-Amar E, Hugon J, Paquet C, Blennow K. The presynaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease. Alzheimers Res Ther. 2016. October 3;8(1):41. doi: 10.1186/s13195-016-0208-8. PubMed PMID: 27716408;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-016-0208-8</ArticleId><ArticleId IdType="pmc">PMC5048479</ArticleId><ArticleId IdType="pubmed">27716408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>